Literature DB >> 27436494

Elevated Levels of Adhesion Proteins Are Associated With Low Ankle-Brachial Index.

Cecilia Berardi1,2, Christine L Wassel3, Paul A Decker2, Nicholas B Larson2, Phillip S Kirsch2, Mariza de Andrade2, Michael Y Tsai4, James S Pankow5, Michele M Sale6, Hugues Sicotte2, Weihong Tang5, Naomi Q Hanson4, Mary M McDermott7, Michael H Criqui8, Michael A Allison8, Suzette J Bielinski2.   

Abstract

Inflammation plays a pivotal role in peripheral artery disease (PAD). Cellular adhesion proteins mediate the interaction of leukocytes with endothelial cells during inflammation. To determine the association of cellular adhesion molecules with ankle-brachial index (ABI) and ABI category (≤1.0 vs >1.0) in a diverse population, 15 adhesion proteins were measured in the Multi-Ethnic Study of Atherosclerosis (MESA). To assess multivariable associations of each protein with ABI and ABI category, linear and logistic regression was used, respectively. Among 2364 participants, 23 presented with poorly compressible arteries (ABI > 1.4) and were excluded and 261 had ABI ≤ 1.0. Adjusting for traditional risk factors, elevated levels of soluble P-selectin, hepatocyte growth factor, and secretory leukocyte protease inhibitor were associated with lower ABI ( P = .0004, .001, and .002, respectively). Per each standard deviation of protein, we found 26%, 20%, and 19% greater odds of lower ABI category ( P = .001, .01, and .02, respectively). Further investigation into the adhesion pathway may shed new light on biological mechanisms implicated in PAD.

Entities:  

Keywords:  P-selectin; ankle–brachial index; hepatocyte growth factor; peripheral artery disease; secretory leukocyte protease inhibitor

Mesh:

Substances:

Year:  2016        PMID: 27436494      PMCID: PMC5247409          DOI: 10.1177/0003319716659178

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  50 in total

1.  Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.

Authors:  Kathrin Rychli; Bernhard Richter; Philipp J Hohensinner; Ali Kariem Mahdy; Stephanie Neuhold; Gerlinde Zorn; Rudolf Berger; Deddo Mörtl; Kurt Huber; Richard Pacher; Johann Wojta; Alexander Niessner; Martin Hülsmann
Journal:  Heart       Date:  2011-05-14       Impact factor: 5.994

2.  Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.

Authors:  P C Bennett; P S Gill; S Silverman; A D Blann; J Chackathayil; G Y H Lip
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

3.  Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study.

Authors:  Irene M van der Meer; Moniek P M de Maat; Michiel L Bots; Monique M B Breteler; John Meijer; Amanda J Kiliaan; Albert Hofman; Jacqueline C M Witteman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

4.  Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.

Authors:  Kiat T Tan; Muzahir H Tayebjee; Cheryl Lynd; Andrew D Blann; Gregory Y H Lip
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

5.  The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Michael H Criqui; Robyn L McClelland; Mary M McDermott; Matthew A Allison; Roger S Blumenthal; Victor Aboyans; Joachim H Ix; Gregory L Burke; Kaing Liu; Steven Shea
Journal:  J Am Coll Cardiol       Date:  2010-10-26       Impact factor: 24.094

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Influence of secretory leukocyte protease inhibitor-based peptides on elastase activity and their incorporation in hyaluronic acid hydrogels for chronic wound therapy.

Authors:  Sandra Cerqueira Barros; José Alberto Martins; João Carlos Marcos; Artur Cavaco-Paulo
Journal:  Biopolymers       Date:  2012       Impact factor: 2.505

8.  Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.

Authors:  Yiwen Li; Genzou Takemura; Ken-ichiro Kosai; Kentaro Yuge; Satoshi Nagano; Masayasu Esaki; Kazuko Goto; Tomoyuki Takahashi; Kenji Hayakawa; Masahiko Koda; Yukinori Kawase; Rumi Maruyama; Hideshi Okada; Shinya Minatoguchi; Hiroyuki Mizuguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

9.  Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease.

Authors:  Silvia Bleda; Joaquin De Haro; Francisco Acin; Cesar Varela; Leticia Esparza; Ignacio López de Maturana
Journal:  Ann Vasc Surg       Date:  2013-02-10       Impact factor: 1.466

10.  Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.

Authors:  Himabindu Vidula; Lu Tian; Kiang Liu; Michael H Criqui; Luigi Ferrucci; William H Pearce; Philip Greenland; David Green; Jin Tan; Daniel B Garside; Jack Guralnik; Paul M Ridker; Nader Rifai; Mary M McDermott
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

View more
  2 in total

1.  Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study.

Authors:  Jan K Nowak; Irena Wojsyk-Banaszak; Edyta Mądry; Andrzej Wykrętowicz; Patrycja Krzyżanowska; Sławomira Drzymała-Czyż; Agata Nowicka; Andrzej Pogorzelski; Ewa Sapiejka; Wojciech Skorupa; Mariusz Szczepanik; Aleksandra Lisowska; Jaroslaw Walkowiak
Journal:  Lung       Date:  2017-06-23       Impact factor: 2.584

2.  Association of Circulating Hepatocyte Growth Factor and Risk of Incident Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Parveen K Garg; Petra Buzkova; Christina L Wassell; Matthew Allison; Michael Criqui; Nicholas B Larson; Suzette J Bielinski
Journal:  Angiology       Date:  2020-03-23       Impact factor: 3.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.